Tag: dual antiplatelet therapy
SVS member named 2023 Presidential Leadership Scholar
Society for Vascular Surgery (SVS) member Anahita Dua, MD, has been named a Presidential Leadership Scholar for 2023.
She is one of 60 scholars in...
SCVS 2023: DAPT linked to better post-TCAR outcomes versus other drug...
Recent data presentations have revealed reduced risks of stroke and mortality among transcarotid artery revascularization (TCAR) patients who receive dual antiplatelet therapy (DAPT)—both preoperatively...
SCVS 2023: DAPT shows higher survival rate in patients with low...
A retrospective cohort study presented at the 2023 Society for Clinical Vascular Surgery (SCVS) Annual Symposium in Miami (March 25–29) has found lower-extremity bypass...
DAPT linked to better post-TCAR outcomes versus other drug regimens
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid disease...